Bristol-Myers Squibb Aktie
WKN: 850501 / ISIN: US1101221083
|
02.02.2024 13:07:20
|
Bristol-Myers Squibb Co. Q4 Profit Decreases, but beats estimates
(RTTNews) - Bristol-Myers Squibb Co. (BMY) announced a profit for fourth quarter that decreased from last year but beat the Street estimates.
The company's bottom line totaled $1.76 billion, or $0.87 per share. This compares with $2.02 billion, or $0.95 per share, in last year's fourth quarter.
Excluding items, Bristol-Myers Squibb Co. reported adjusted earnings of $3.47 billion or $1.70 per share for the period.
Analysts on average had expected the company to earn $1.53 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 0.6% to $11.48 billion from $11.41 billion last year.
Bristol-Myers Squibb Co. earnings at a glance (GAAP) :
-Earnings (Q4): $1.76 Bln. vs. $2.02 Bln. last year. -EPS (Q4): $0.87 vs. $0.95 last year. -Analyst Estimates: $1.53 -Revenue (Q4): $11.48 Bln vs. $11.41 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bristol-Myers Squibb Co.mehr Nachrichten
Analysen zu Bristol-Myers Squibb Co.mehr Analysen
Aktien in diesem Artikel
| Bristol-Myers Squibb Co. | 37,03 | 0,64% |
|